Evidence map›Paper›PMID 25231110›Full record

ArticleBirth defects research. Part B, Developmental and reproductive toxicology2014

Ketamine affects the neurogenesis of rat fetal neural stem progenitor cells via the PI3K/Akt-p27 signaling pathway.

Chaoxuan Dong, Cynthia R Rovnaghi, Kanwaljeet J S Anand

Open access · greenAbstract read
In one paragraph

Article in Birth defects research. Part B, Developmental and reproductive toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Chaoxuan DongDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee; Department of Anatomy and Neurobiology, Neuroscience Institute, University of Tennessee Health Science Center, Memphis, Tennessee.
Cynthia R Rovnaghi
Kanwaljeet J S Anand
University of Tennessee Health Science Center · USLe Bonheur Children's Hospital · US

Funding

PCCM Network: Remedies for Opioid Tolerance &WithdrawalU10HD050009 · NICHD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI SANDERS, RONALD C · 2005 to 2009
$1.7M
NICHD NIH HHS U10 HD050009NICHD NIH HHS U10-HD50009
6 · The paper itself

Abstract

Ketamine is widely used as an anesthetic, analgesic, or sedative in pediatric patients. We reported that ketamine alters the normal neurogenesis of rat fetal neural stem progenitor cells (NSPCs) in the developing brain, but the underlying mechanisms remain unknown. The PI3K-PKB/Akt (phosphatidylinositide 3-kinase/protein kinase B) signaling pathway plays many important roles in cell survival, apoptosis, and proliferation. We hypothesized that PI3K-PKB/Akt signaling may be involved in ketamine-altered neurogenesis of cultured NSPCs in vitro. NSPCs were isolated from Sprague-Dawley rat fetuses on gestational day 17. 5-bromo-2'-deoxyuridine (BrdU) incorporation, Ki67 staining, and differentiation tests were utilized to identify primary cultured NSPCs. Immunofluorescent staining was used to detect Akt expression, whereas Western blots measured phosphorylated Akt and p27 expression in NSPCs exposed to different treatments. We report that cultured NSPCs had properties of neurogenesis: proliferation and neural differentiation. PKB/Akt was expressed in cultured rat fetal cortical NSPCs. Ketamine inhibited the phosphorylation of Akt and further enhanced p27 expression in cultured NSPCs. All ketamine-induced PI3K/Akt signaling changes could be recovered by N-methyl-d-aspartate (NMDA) receptor agonist, NMDA. These data suggest that the inhibition of PI3K/Akt-p27 signaling may be involved in ketamine-induced neurotoxicity in the developing brain, whereas excitatory NMDA receptor activation may reverse these effects.

Indexed as

AnalgesicsAnimalsBrainCell ProliferationCells, CulturedCyclin-Dependent Kinase Inhibitor p27KetamineMAP Kinase Signaling SystemNeural Stem CellsNeurogenesisN-MethylaspartatePhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyAnalgesicsCdkn1b protein, ratCyclin-Dependent Kinase Inhibitor p27KetamineN-MethylaspartatePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, N-Methyl-D-Aspartateembryogenesisembryonic/fetal physiologypharmaceuticalssafety assessmentsignal transduction

Identifiers

PMID25231110
PMCPMC4330101
OpenAlexW2105605689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.